Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation i FL5.12 pro-B cells convert it into prodeath factor

Cell Death and Differentiation

Volumn 12, Issue 9, 2005, Pages 1225-1239

  Kucharczak, J F ^a,e   Simmons, M J ^a,b   Duckett, C S ^c   Gelinas C ^a,d  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e Centre National de la Recherche Scientifique   (France)

Author keywords

A1; Apoptosis; Bfl 1; Calpain; Proteasome; Ubiquitin

Indexed keywords

BH3 PROTEIN; CALPAIN; CASPASE; CYCLOHEXIMIDE; CYTOKINE; GREEN FLUORESCENT PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; LYSINE; PROTEASOME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BFL 1/A1; SERINE; STAUROSPORINE; THREONINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE MUTATION; GENETIC TRANSFECTION; IMMUNOBLOTTING; IN VITRO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TUMOR CELL; UBIQUITINATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CALPAIN; CELL DEATH; CELL LINE; CYCLOHEXIMIDE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; LYSINE; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; PHENOTYPE; PLASMIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SEQUENCE HOMOLOGY, AMINO ACID; STAUROSPORINE; TRANSFECTION; UBIQUITIN;

EID: 22344436226     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401684     Document Type: Article

References (70)

1. Adams JM and Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326
2. Cory S and Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2: 647-656
3. Petros AM, Olejniczak ET and Fesik SW (2004) Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644: 83-94
4. Cheng EH, Wei M, Weiler S, Flavell RA, Mak TW, Lindsten T and Korsmeyer SJ (2001) BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8: 705-711
5. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S and Korsmeyer SJ (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183-192
6. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM and Huang DCS (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17: 393-403
7. Chittenden T (2002) BH3 domains: intracellular death-ligands critical for initiating apoptosis. Cancer Cell 2: 165-166
8. Walensky LD, Kung AL, Escher I, Malia TJ, Barbuto S, Wright RD, Wagner G, Verdine GL and Korsmeyer SJ (2004) Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305: 1466-1470
9. Clem RJ, Cheng EH, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA and Hardwick JM (1998) Modulation of cell death by Bcl-xL through caspase interaction. Proc. Natl. Acad. Sci. USA 95: 554-559
10. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K and Hardwick JM (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968
11. Nakagawa T and Yuan J (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol. 150: 887-894
12. Wang K (2000) Calpain or caspase: can you tell the difference? Trends Neurosci. 23: 20-26
13. Chan SL and Mattson MP (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58: 167-190
14. Choi SS, Park I-C, Yun JW, Sung YC, Hong S-I and Shin H-S (1995) A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11: 1693-1698
15. Lin EY, Orlofsky A, Berger MS and Prystowsky MB (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151: 1979-1988
16. Hirotani M, Zhang Y, Fujita N, Naito M and Tsuruo T (1999) NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis. J. Biol. Chem. 274: 20415-20420
17. Zhang H, Cowan-Jacob SW, Simonen M, Greenhalf W, Heim J and Meyhack B (2000) Structural basis of Bfl-1 for its interaction with Bax and anti-apoptotic action in mammalian and yeast cells. J. Biol. Chem. 275: 11092-11099
18. (a) Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB and Korsmeyer SJ (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92: 7834-7838
19. D'Sa-Eipper C and Chirmadurai G (1998) Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene 16: 3105-3114
20. Hatakeyama S, Hamasaki A, Negishi I, Loh DY, Sendo F and Nakayama K (1998) Multiple gene duplication and expression of mouse bcl-2-related genes, A1. Int. Immunol. 10: 631-637
21. Ko JK, Lee MJ, Cho SH, Cho JA, Lee BY, Koh JS, Lee SS, Shim YH and Kim CW (2003) Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death. Oncogene 22: 2457-2465
22. Kenny JJ, Knobloch TJ, Augustus M, Carter KC, Rosen CA and Lang JC (1997) GRS, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes. Oncogene 14: 997-1001
23. Zong WX, Edelstein LC, Chen C, Bash J and Gélinas C (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13: 382-387
24. Hu X, Yee E, Harlan JM, Wong F and Karsan A (1998) Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 92: 2759-2765
25. Lee HH, Dadgostar H, Cheng Q, Shu J and Cheng G (1999) NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96: 9136-9141
26. Wang CY, Guttridge DC, Mayo MW and Baldwin Jr AS (1999) NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19: 5923-5929
27. Grumont RJ, Rourke IJ and Gerondakis S (1999) Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13: 400-411
28. (a) Edelstein LC, Lagos L, Simmons M, Tirumalai H and Gélinas C (2003) NF-κB-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bf1-1/A1, Mol. Cell. Biol. 23: 2749-2761
29. Somogyi RD, Wu Y, Orlofsky A and Prystowsky MB (2001) Transient expression of the Bcl-2 family member, A1-a, results in nuclear localization and resistance to staurosporine-induced apoptosis. Cell Death Diff. 8: 785-793
30. Werner AB, de Vries E, Tait SWG, Bontjer I and Borst J (2002) Bcl-2 family member Bfl-1/A1 sequesters truncated Bid to inhibit its collaboration with pro-apoptotic Bak or Bax. J. Biol. Chem. 277: 22781-22788
31. D'Sa-Eipper C, Subramanian T and Chinnadurai G (1996) Bfl-1, a Bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res. 56: 3879-3882
32. Karsan A, Yee E and Harlan JM (1996) Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271: 27201-27204
33. Liang Y, Nylander KD, Yan C and Schor NF (2002) Role of caspase-3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2. Mol. Pharmacol. 61: 142-149
34. Kirsch DG, Doseff A, Chau BN, Lim DS, de Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA and Hardwick JM (1999) Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. 274: 21155-21161
35. Johnson BW and Boise LH (1999) Bcl-2 and caspase inhibition cooperate to inhibit tumor necrosis factor-alpha-induced cell death in a Bcl-2 cleavage-independent fashion. J. Biol. Chem. 274: 18552-18558
36. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D and Goldberg AL (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771
37. Fuchs SY, Fried VA and Ronai Z (1998) Stress-activated kinases regulate protein stability. Oncogene 17: 1483-1490
38. Mandic A, Viktorsson K, Strandberg L, Heiden T, Hansson J, Linder S and Shoshan MC (2002) Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol. Cell. Biol. 22: 3003-3013
39. Wood DE, Thomas A, Devi LA, Berman Y, Beavis RC, Reed JC and Newcomb EW (1998) Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17: 1069-1078
40. Choi WS, Lee EH, Chung CW, Jung YK, Jin BK, Kim SU, Oh TH, Saido TC and Oh YJ (2001) Cleavage of Bax is mediated by caspase-dependent or - independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J. Neurochem. 77: 1531-1541
41. Mellgren RL (1997) Specificities of cell permeant peptidyl inhibitors for the proteinase activities of μ-calpain and the 20S proteasome. J. Biol. Chem. 272: 29899-29903
42. Griscavage JM, Wilk S and Ignarro LJ (1995) Serine and cysteine proteinase inhibitors prevent nitric oxide production by activated macrophages by interfering with transcription of the inducible NO synthase gene. Biochem. Biophys. Res. Commun. 215: 721-729
43. Duriez PJ, Wong F, Dorovini-Zis K, Shahidi R and Karsan A (2000) A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J. Biol. Chem. 275: 18099-18107
44. Ko JK, Choi KH, Kim HJ, Choi HY, Yeo DJ, Park SO, Yang WS, Kim YN and Kim CW (2003) Conversion of Bfl-1, an anti-apoptotic Bcl-2 family protein, to a potent pro-apoptotic protein by fusion with green fluorescent protein (GFP). FEBS Lett. 551: 29-36
45. Cuconati A, Mukherjee C, Perez D and White E (2003) DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev. 17: 2922-2932
46. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F and Wang X (2003) Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17: 1475-1486
47. Dimmeler S, Breitschopf K, Haendeler J and Zeiher AM (1999) Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189: 1815-1822
48. Breitschopf K, Haendeler J, Malchow P, Zeiher AM and Dimmeler S (2000) Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol. Cell. Biol. 20: 1886-1896
49. Deng X, Gao F, Flagg T and May WS (2004) Mono- and multisite phosphorylation enhances Bcl-2's antiapoptotic function and inhibition of cell cycle entry functions. Proc. Natl. Acad. Sci. USA 101: 153-158
50. Goll DE, Thompson VF, Li H, Wei W and Cong J (2003) The calpain system. Physiol. Rev. 83: 731-801
51. Ruiz-Vela A, Gonzalez de Buitrago G and Martinez AC (1999) Implication of calpain in caspase activation during B cell clonal deletion. EMBO J. 18: 4988-4998
52. Wolf BB, Goldstein JC, Beere H, Amarante-Mentes GP, Salvesen GS and Green DR (1999) Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 94: 1683-1692
53. Chua BT, Guo K and Li P (2000) Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases. J. Biol. Chem. 275: 5131-5135
54. McGinnis KM, Gnegy ME, Park YH, Mukerjee N and Wang KK (1999) Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem. Biophys. Res. Commun. 263: 94-99
55. Porn-Ares MI, Samali A and Orrenius S (1998) Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ. 5: 1028-1033
56. Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, Talanian RV, Keegan M, Herzog L and Allen H (1998) Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 356: 187-196
57. Saido TC, Sorimachi H and Suzuki K (1994) Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8: 814-822
58. Altznauer F, Conus S, Cavalli A, Folkers G and Simon HU (2004) Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J. Biol. Chem. 279: 5947-5957
59. Merino R, Ding L, Veis DJ, Korsmeyer SJ and Nunez G (1994) Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 13: 683-691
60. Reed JC (1996) A day in the life of the Bcl-2 protein: does the turnover rate of Bcl-2 serve as a biological clock for cellular lifespan regulation? Leuk. Res. 20: 109-111
61. Fujita N, Nagahashi A, Nagashima K, Rokudai S and Tsuruo T (1998) Acceleration of apoptotic cell death after cleavage of Bcl-xL protein by caspase-3-like proteases. Oncogene 17: 1295-1304
62. 2+ level. J. Neurosci. Res. 44: 374-380
63. Melloni E, Pontremoli S, Michetti M, Sacco O, Sparatore B and Horecker BL (1986) The involvement of calpain in the activation of protein kinase C in neutrophils stimulated by phorbol myrstic acid. J. Biol. Chem. 261: 4101-4105
64. Eto A, Akita Y, Saido TC, Suzuki K and Kawashima S (1995) The role of the calpain-calpastatin system in thyrotropin-releasing hormone-induced selective down-regulation of a protein kinase C isozyme, nPKC epsilon, in rat pituitary GH4C1 cells. J. Biol. Chem. 270: 25115-25120
65. Alizadeh A, Eisen M, Davis R, Ma C, Lossos I, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson WH, Greyer MR, Byrd JC, Botstein D, Brown PO and Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511
66. Debatin KM, Poncet D and Kroemer G (2002) Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21: 8786-8803
67. Hinz M, Loser P, Mathas S, Krappmann D, Dorken B and Scheidereit C (2001) Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 97: 2798-2807
68. Boise L, Gonzalez-Garcia M, Postema C, Ding L, Lindsten T, Turka L, Mao X, Nunez G and Thompson C (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608
69. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
70. Shumway SD, Maki M and Miyamoto S (1999) The PEST domain of IkBa is necessary and sufficient for in vitro degradation by μ-calpain. J. Biol. Chem. 274: 30874-30881